Seizert Capital Partners LLC Sells 33,701 Shares of Centene Co. (NYSE:CNC)

Seizert Capital Partners LLC decreased its position in shares of Centene Co. (NYSE:CNC - Free Report) by 30.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 78,440 shares of the company's stock after selling 33,701 shares during the period. Seizert Capital Partners LLC's holdings in Centene were worth $4,752,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Capital Advisors Ltd. LLC lifted its position in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company's stock worth $25,000 after buying an additional 177 shares during the last quarter. SRS Capital Advisors Inc. boosted its stake in shares of Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company's stock valued at $38,000 after purchasing an additional 267 shares in the last quarter. Riverview Trust Co grew its holdings in shares of Centene by 172.7% during the 4th quarter. Riverview Trust Co now owns 758 shares of the company's stock valued at $46,000 after purchasing an additional 480 shares during the last quarter. Private Trust Co. NA lifted its stake in Centene by 75.3% in the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company's stock valued at $58,000 after purchasing an additional 332 shares during the last quarter. Finally, True Wealth Design LLC bought a new stake in shares of Centene during the third quarter worth $66,000. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Thomas Greco bought 17,000 shares of the business's stock in a transaction that occurred on Wednesday, December 18th. The shares were bought at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the transaction, the director now directly owns 19,309 shares in the company, valued at approximately $1,153,712.75. This represents a 736.25 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Theodore R. Samuels II acquired 5,000 shares of the company's stock in a transaction on Friday, December 13th. The shares were bought at an average price of $58.86 per share, for a total transaction of $294,300.00. Following the completion of the purchase, the director now owns 23,000 shares in the company, valued at approximately $1,353,780. This represents a 27.78 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 23,693 shares of company stock worth $1,409,954 in the last ninety days. Corporate insiders own 0.33% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms recently weighed in on CNC. Stephens cut their price objective on Centene from $75.00 to $73.00 and set an "equal weight" rating on the stock in a report on Friday, December 13th. Truist Financial reduced their price target on Centene from $89.00 to $84.00 and set a "buy" rating on the stock in a report on Friday, December 13th. Oppenheimer cut their target price on shares of Centene from $95.00 to $85.00 and set an "outperform" rating on the stock in a research report on Friday, December 13th. Jefferies Financial Group downgraded shares of Centene from a "hold" rating to an "underperform" rating and dropped their price target for the company from $68.00 to $52.00 in a research note on Tuesday, December 10th. Finally, StockNews.com cut shares of Centene from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 6th. One research analyst has rated the stock with a sell rating, five have given a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $79.92.

Centene Stock Up 1.0 %

Shares of Centene stock traded up $0.58 during trading on Friday, reaching $60.03. 5,511,138 shares of the company traded hands, compared to its average volume of 4,663,938. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.11 and a quick ratio of 1.10. The firm has a market capitalization of $29.78 billion, a PE ratio of 9.62, a P/E/G ratio of 0.80 and a beta of 0.40. The company has a 50 day moving average price of $60.82 and a 200-day moving average price of $64.61. Centene Co. has a 1-year low of $55.03 and a 1-year high of $80.59.

Centene (NYSE:CNC - Get Free Report) last issued its earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.49 by $0.31. The company had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The firm's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period last year, the business posted $0.45 EPS. As a group, equities research analysts expect that Centene Co. will post 6.86 earnings per share for the current fiscal year.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.